{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Brooksville",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "64188",
      "recalling_firm": "TG United, Inc.",
      "address_1": "16275 Aviation Loop Dr",
      "address_2": "N/A",
      "postal_code": "34604-6805",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "FL, MS, SC, LA  and TX",
      "recall_number": "D-513-2013",
      "product_description": "AMBI 40PSE/400GFN, 100 tablet bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0408-01",
      "product_quantity": "886 bottles  - 100-count tablets",
      "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.",
      "recall_initiation_date": "20130130",
      "center_classification_date": "20130604",
      "termination_date": "20160930",
      "report_date": "20130612",
      "code_info": "Lot # 12C007 Exp. 02/14; Lot # 12C008 Exp. 02/14."
    }
  ]
}